Arch Pediat Adol Med
-
Arch Pediat Adol Med · Oct 2000
Randomized Controlled Trial Multicenter Study Clinical TrialHigher-dose intravenous magnesium therapy for children with moderate to severe acute asthma.
To evaluate the efficacy of a 40-mg/kg dose of intravenous magnesium sulfate for moderate to severe asthma exacerbations in pediatric patients. ⋯ Children treated with 40 mg/kg of intravenous magnesium sulfate for moderate to severe asthma showed remarkable improvement in short-term pulmonary function.